Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...
The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...
A singing group is helping people with respiratory conditions improve their breathing. Singing For Lung Health supports patients who live with chronic conditions such as emphysema, long Covid and ...
Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...
The one-year mark signals a lot of success for Newman Regional Health’s Pulmonary Rehabilitation Department. That was the assessment from Cardiopulmonary Director Donny Bellomy and Pulmonary Rehab ...
This interactive map explains where COPD rates, hospitalizations, and deaths are highest across the United States.
For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis ...
People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
D. Boral Capital initiated coverage of Pulmonx (LUNG) with a Buy rating and $17 price target The firm says Pulmonx is a commercial-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results